SCHEMBL12326836

SCHEMBL12326836

CC(=O)c1ccc(C(C)(C)C)c([N+](=O)[O-])c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.51
CHEK1 O14757 1/20 0.49
PDE7A Q13946 1/20 0.49
MAPK1 P28482 3/20 0.49
POLB P06746 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
ALDH1A1 P00352 1/20 0.47
TSHR P16473 1/20 0.46
CASP6 P55212 1/20 0.46
KMT2A Q03164 2/20 0.46
MEN1 O00255 1/20 0.46
ATM Q13315 2/20 0.45
NPC1 O15118 1/20 0.45
LMNA P02545 1/20 0.45
RAB9A P51151 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
PKM P14618 1/20 0.44
AKR1C3 P42330 1/20 0.44
AKR1C2 P52895 1/20 0.44
VCAM1 P19320 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16960436 0.88 CHEK1 (0.47) MAPTCHEK1MAPK1L3MBTL1ALDH1A1
SCHEMBL3855174 0.87 CASP6 (0.64) POLBTSHRCASP6KMT2AMEN1
SCHEMBL3847201 0.85 PARP1 (0.59) MAPTCHEK1POLBL3MBTL1ALDH1A1
SCHEMBL8129502 0.83 VCAM1 (0.63) CHEK1ALDH1A1KMT2AMEN1LMNA
SCHEMBL16950587 0.83 CHEK1 (0.44) MAPTCHEK1L3MBTL1ALDH1A1TSHR
SCHEMBL8129652 0.83 ALDH1A1 (0.53) MAPTCHEK1ALDH1A1TSHRCASP6
SCHEMBL8149078 0.83 CHEK1 (0.55) MAPTCHEK1MAPK1POLBALDH1A1
SCHEMBL16951335 0.81 CHEK1 (0.43) MAPTCHEK1POLBL3MBTL1ALDH1A1
SCHEMBL16951893 0.81 CHEK1 (0.43) MAPTCHEK1MAPK1POLBL3MBTL1
Dimethylamine SCHEMBL8186390 0.81 PARP1 (0.55) MAPTCHEK1POLBL3MBTL1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8299055-B2 8-substituted isoquinoline derivative and the use thereof ASAHI KASEI PHARMA CORPORATION (JP) 2012-10-30 US disclosed
EP-2366699-A1 8-SUBSTITUTED ISOQUINOLINE DERIVATIVE AND USE THEREOF Asahi Kasei Pharma Corporation (JP) 2011-09-21 EP disclosed
US-20100261701-A1 8-Substituted isoquinoline derivative and the use thereof ASAHI KASEI PHARMA CORPORATION (JP) 2010-10-14 US disclosed
WO-2010038465-A1 8-SUBSTITUTED ISOQUINOLINE DERIVATIVE AND USE THEREOF 旭化成ファーマ株式会社 (JP) 2010-04-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100261701-A1 8-Substituted isoquinoline derivative and the use thereof RELA, NFKBIA, NFKB2 MAPT 3817/4885CHEK1 1650/4885PDE7A 2942/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.